This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Hepatocellular Carcinoma
and you are
between 18 and 75
years old
The phase for this study is not defined.
Show me locations

The purpose

This study aims at testing the utility of PET Scan as a screening tool for liver transplantation in patients with Hepatocellular Carcinoma. Patients being worked up for liver transplant for hepatocellular carcinoma will undergo a PET Scan and will be followed until 2 years after transplantation. At that time survival data will be analysed according to PET Scan results to determine if it can be used to predict outcome.

Provided treatments

  • Other: PET Scan

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01320852. The sponsor of the trial is McGill University Health Centre/Research Institute of the McGill University Health Centre and it is looking for 100 volunteers for the current phase.
Official trial title:
PET Scan as a Screening Tool for Liver Transplant in Patients With HCC